A retrospective survival analysis examined the association of acetylcholinesterase inhibitors with mortality in a large cohorts of patients with Alzheimer’s disease from one of the largest healthcare providers in Europe in an evaluation for mental disorders and dementia. The gene discussed is ACHE; the disease is early-onset autosomal dominant Alzheimer disease.